Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco J Vizeacoumar

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Oncotarget|July 16, 2016
Targeting synthetic lethality between the SRC kinase and the EPHB6 receptor may benefit cancer treatmentJames M Paul, Behzad Toosi, Frederick S Vizeacoumar, et al.
Elife|April 19, 2024
MEMO1 binds iron and modulates iron homeostasis in cancer cellsNatalia Dolgova, Eva-Maria E Uhlemann, Michal T Boniecki, et al.
The Journal of Cell Biology|January 13, 2010
Integrating high-throughput genetic interaction mapping and high-content screening to explore yeast spindle morphogenesisFranco J Vizeacoumar, Nydia van Dyk, Frederick S Vizeacoumar, et al.
Cancers|March 13, 2024
Breast Tumor Metastasis and Its Microenvironment: It Takes Both Seed and Soil to Grow a Tumor and Target It for TreatmentShirin Bonni, David N Brindley, M Dean Chamberlain, et al.
Molecular Oncology|December 15, 2018
Molecular characterization of an MLL1 fusion and its role in chromosomal instabilitySreejit Parameswaran, Frederick S Vizeacoumar, Kalpana Kalyanasundaram Bhanumathy, et al.
Pathogens (Basel, Switzerland)|November 27, 2021
Highly Specific Sigma Receptor Ligands Exhibit Anti-Viral Properties in SARS-CoV-2 Infected CellsDavid A Ostrov, Andrew P Bluhm, Danmeng Li, et al.
Cancers|September 9, 2022
Activation of the Anaphase Promoting Complex Reverses Multiple Drug Resistant Cancer in a Canine Model of Multiple Drug Resistant LymphomaTerra G Arnason, Valerie MacDonald-Dickinson, Matthew Casey Gaunt, et al.
Gynecologic Oncology|October 11, 2023
Survey of NF1 inactivation by surrogate immunohistochemistry in ovarian carcinomasMartin Köbel, Rui Zhe Yang, Eun Young Kang, et al.
Science Advances|August 28, 2021
Genome-wide synthetic lethal screen unveils novel CAIX-NFS1/xCT axis as a targetable vulnerability in hypoxic solid tumorsShawn C Chafe, Frederick S Vizeacoumar, Geetha Venkateswaran, et al.
Oncogene|April 29, 2025
A novel role for Neurog2 in MYCN driven neuroendocrine plasticity of prostate cancerPrachi Walke, Jared D W Price, Frederick S Vizeacoumar, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Oncotarget|July 16, 2016
Targeting synthetic lethality between the SRC kinase and the EPHB6 receptor may benefit cancer treatmentJames M Paul, Behzad Toosi, Frederick S Vizeacoumar, et al.
Elife|April 19, 2024
MEMO1 binds iron and modulates iron homeostasis in cancer cellsNatalia Dolgova, Eva-Maria E Uhlemann, Michal T Boniecki, et al.
The Journal of Cell Biology|January 13, 2010
Integrating high-throughput genetic interaction mapping and high-content screening to explore yeast spindle morphogenesisFranco J Vizeacoumar, Nydia van Dyk, Frederick S Vizeacoumar, et al.
Cancers|March 13, 2024
Breast Tumor Metastasis and Its Microenvironment: It Takes Both Seed and Soil to Grow a Tumor and Target It for TreatmentShirin Bonni, David N Brindley, M Dean Chamberlain, et al.
Molecular Oncology|December 15, 2018
Molecular characterization of an MLL1 fusion and its role in chromosomal instabilitySreejit Parameswaran, Frederick S Vizeacoumar, Kalpana Kalyanasundaram Bhanumathy, et al.
Pathogens (Basel, Switzerland)|November 27, 2021
Highly Specific Sigma Receptor Ligands Exhibit Anti-Viral Properties in SARS-CoV-2 Infected CellsDavid A Ostrov, Andrew P Bluhm, Danmeng Li, et al.
Cancers|September 9, 2022
Activation of the Anaphase Promoting Complex Reverses Multiple Drug Resistant Cancer in a Canine Model of Multiple Drug Resistant LymphomaTerra G Arnason, Valerie MacDonald-Dickinson, Matthew Casey Gaunt, et al.
Gynecologic Oncology|October 11, 2023
Survey of NF1 inactivation by surrogate immunohistochemistry in ovarian carcinomasMartin Köbel, Rui Zhe Yang, Eun Young Kang, et al.
Science Advances|August 28, 2021
Genome-wide synthetic lethal screen unveils novel CAIX-NFS1/xCT axis as a targetable vulnerability in hypoxic solid tumorsShawn C Chafe, Frederick S Vizeacoumar, Geetha Venkateswaran, et al.
Oncogene|April 29, 2025
A novel role for Neurog2 in MYCN driven neuroendocrine plasticity of prostate cancerPrachi Walke, Jared D W Price, Frederick S Vizeacoumar, et al.
Pageof 8